Latest News about AZN
Recent news which mentions AZN
Merck and AstraZeneca's Cancer Drug Wins 3 New Approvals in Japan
December 28, 2020
From Motley Fool
PreMarket Prep Stock Of The Day: AstraZeneca
December 28, 2020
From Benzinga
From Benzinga
Novavax Investors Pull Back As Biopharma Launches Phase 3 Coronavirus Vaccine Study
December 28, 2020
From Benzinga
A Peek Into The Markets: US Stock Futures Gain As Trump Signs $900B Covid-19 Relief Bill
December 28, 2020
From Benzinga
5 Stocks To Watch For December 28, 2020
December 28, 2020
From Benzinga
European stocks and U.S. equity futures trade higher as investors welcome U.S. stimulus package and Brexit deal
December 28, 2020
From MarketWatch
AstraZeneca COVID-19 Vaccine To Get UK Approval As Soon As Tuesday: FT
December 27, 2020
From Benzinga
When Will Kids Get COVID Vaccines?
December 27, 2020
From Motley Fool
The 3 Best Healthcare Stocks to Buy for 2021
December 27, 2020
From Motley Fool
Should Investors Be Stashing Cash for 2021?
December 27, 2020
From Motley Fool
Could AstraZeneca's COVID Vaccine Still Succeed?
December 26, 2020
From Motley Fool
Meet Moderna's Most Likely Blockbusters After Its COVID Vaccine
December 24, 2020
From Motley Fool
Better Buy: Veeva Systems vs. Zendesk
December 23, 2020
From Motley Fool
U.S. COVID-19 deaths surge back to more than 3,000 a day as hospitalizations spike to another record
December 23, 2020
From MarketWatch
AstraZeneca’s COVID-19 vaccine could be approved in U.K. ‘shortly after Christmas’ – top Oxford scientist says
December 23, 2020
From MarketWatch
A Peek Into The Markets: US Stock Futures Up Ahead Of Economic Reports
December 23, 2020
From Benzinga
5 Stocks To Watch For December 23, 2020
December 23, 2020
From Benzinga
From Benzinga
Genprex's Leading Drug Candidate Is Currently Being Developed As A Treatment For Lung Cancer
December 22, 2020
From Benzinga
Do These Coronavirus Vaccine Companies Have a Place in an ESG Portfolio?
December 22, 2020
From Motley Fool
The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes
December 22, 2020
From Benzinga
Is There Still Room for Growth for These 2 Coronavirus Stocks?
December 22, 2020
From Motley Fool
From Benzinga
I earned $100,000 last year, but I did not make as much in 2020. Why did I not get a stimulus check? Do you think that’s fair?
December 22, 2020
From MarketWatch
Should Investors Consider This Biotech Takeover Target?
December 21, 2020
From Motley Fool
Is AstraZeneca Paying Too Much for Alexion?
December 21, 2020
From Motley Fool
CDC Says Over 556,208 Pfizer/BioNTech COVID-19 Shots Administered In Week 1 Of Inoculation Drive
December 21, 2020
From Benzinga
3 Great Stocks You Can Buy on Sale
December 20, 2020
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.